CapsoVision, Inc Operating Lease, Right-of-Use Asset, Amortization Expense
CapsoVision, Inc (CV) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $192.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-13
- CapsoVision, Inc operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $98.00K, a 13.95% increase year-over-year.
- CapsoVision, Inc operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $94.00K, a 10.59% increase year-over-year.
- CapsoVision, Inc operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $91.00K, a 12.35% increase year-over-year.
- CapsoVision, Inc operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $89.00K, a 12.66% increase year-over-year.
- CapsoVision, Inc operating lease, right-of-use asset, amortization expense for fiscal 2025 was $351.00K, a 11.43% increase from fiscal 2024.
- CapsoVision, Inc operating lease, right-of-use asset, amortization expense for fiscal 2024 was $315.00K.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $98.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $192.00K 10-Q · filed 2026-08-13 | $283.00K derived: sum of 3 quarters · filed 2026-08-13 | $372.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $94.00K 10-Q · filed 2026-05-14 | $185.00K derived: sum of 2 quarters · filed 2026-05-14 | $274.00K derived: sum of 3 quarters · filed 2026-05-14 | $360.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $91.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $180.00K derived: sum of 2 quarters · filed 2026-03-26 | $266.00K derived: sum of 3 quarters · filed 2026-08-13 | $351.00K 10-K · filed 2026-03-26 |
| 2025-09-30 | $89.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $175.00K derived: sum of 2 quarters · filed 2026-08-13 | $260.00K 10-Q · filed 2025-11-13 | $341.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $86.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $171.00K 10-Q · filed 2026-08-13 | $252.00K derived: sum of 3 quarters · filed 2026-08-13 | $331.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $85.00K 10-Q · filed 2026-05-14 | $166.00K derived: sum of 2 quarters · filed 2026-05-14 | $245.00K derived: sum of 3 quarters · filed 2026-05-14 | |
| 2024-12-31 | $81.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $160.00K derived: sum of 2 quarters · filed 2026-03-26 | $315.00K 10-K · filed 2026-03-26 | |
| 2024-09-30 | $79.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $234.00K 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | $155.00K 10-Q · filed 2025-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B |